...
首页> 外文期刊>Molecular pain >Primary sensory neuron-specific interference of TRPV1 signaling by adeno-associated virus-encoded TRPV1 peptide aptamer attenuates neuropathic pain
【24h】

Primary sensory neuron-specific interference of TRPV1 signaling by adeno-associated virus-encoded TRPV1 peptide aptamer attenuates neuropathic pain

机译:腺相关病毒编码的TRPV1肽适体对TRPV1信号的主要感觉神经元特异性干扰减轻神经性疼痛。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

TRPV1 (transient receptor potential vanilloid subfamily member 1) is a pain signaling channel highly expressed in primary sensory neurons. Attempts for analgesia by systemic TRPV1 blockade produce undesirable side effects, such as hyperthermia and impaired heat pain sensation. One approach for TRPV1 analgesia is to target TRPV1 along the peripheral sensory pathway. For functional blockade of TRPV1 signaling, we constructed an adeno-associated virus (AAV) vector expressing a recombinant TRPV1 interfering peptide aptamer, derived from a 38mer tetrameric assembly domain (TAD), encompassing residues 735 to 772 of rat TRPV1, fused to the C-terminus of enhanced green fluorescent protein (EGFP). AAV-targeted sensory neurons expressing EGFP-TAD after vector injection into the dorsal root ganglia (DRG) revealed decreased inward calcium current and diminished intracellular calcium accumulation in response to capsaicin, compared to neurons of na?ve or expressing EGFP alone. To examine the potential for treating neuropathic pain, AAV-EGFP-TAD was injected into fourth and fifth lumbar (L) DRGs of rats subjected to neuropathic pain by tibial nerve injury (TNI). Results showed that AAV-directed selective expression of EGFP-TAD in L4/L5 DRG neuron somata, and their peripheral and central axonal projections can limit TNI-induced neuropathic pain behavior, including hypersensitivity to heat and, to a less extent, mechanical stimulation. Selective inhibition of TRPV1 activity in primary sensory neurons by DRG delivery of AAV-encoded analgesic interfering peptide aptamers is efficacious in attenuation of neuropathic pain. With further improvements of vector constructs and in?vivo application, this approach might have the potential to develop as an alternative gene therapy strategy to treat chronic pain, especially heat hypersensitivity, without complications due to systemic TRPV1 blockade.
机译:TRPV1(瞬态受体电位类香草亚家族成员1)是在初级感觉神经元中高度表达的疼痛信号通道。尝试通过全身性TRPV1阻滞进行镇痛会产生不良副作用,例如体温过高和热痛感受损。 TRPV1镇痛的一种方法是沿周围感觉途径靶向TRPV1。对于TRPV1信号转导的功能性阻断,我们构建了一种腺相关病毒(AAV)载体,该载体表达重组TRPV1干扰肽适体,其衍生自38mer四聚体组装结构域(TAD),涵盖大鼠TRPV1的735至772位残基,与C融合-绿色荧光蛋白(EGFP)的末端。与单纯或单独表达EGFP的神经元相比,将载体注射到背根神经节(DRG)中后,表达AGFP的感觉神经元表达EGFP-TAD表现出对辣椒素的内向钙流减少和细胞内钙积累减少。为了检查治疗神经性疼痛的潜力,将AAV-EGFP-TAD注射到患有胫骨神经损伤(TNI)的神经性疼痛的大鼠的第四和第五腰(L)DRG中。结果表明,AAV指导的L4 / L5 DRG神经元躯体中EGFP-TAD的选择性表达及其周围和中央轴突投射可限制TNI诱导的神经性疼痛行为,包括对热的超敏反应,并在较小程度上包括机械刺激。通过DRG传递AAV编码的镇痛干扰肽适体对DRG1初级感觉神经元的活性的选择性抑制在减轻神经性疼痛方面有效。随着载体构建物的进一步改进和体内应用,这种方法可能有可能发展为替代基因治疗策略,以治疗慢性疼痛,尤其是热超敏反应,而不会因全身性TRPV1阻断而引起并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号